Vera Therapeutics, Inc. Class short interest in 2026
In 2026, Vera Therapeutics, Inc. Class's disclosed short interest ran from 12.59% of shares outstanding on 15 Jan 2026 to 23.64% on 15 Sep 2026, a change of +11.05 percentage points. The year's high was 27.58% on 31 Aug 2026 and its low 11.95% on 27 Feb 2026, averaging 17.02% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.18 days on 29 May 2026. Full history: Vera Therapeutics, Inc. Class.
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.59% (15 Jan 2026)
- End of year
- 23.64% (15 Sep 2026)
- Change
- +11.05 pp
- High
- 27.58% (31 Aug 2026)
- Low
- 11.95% (27 Feb 2026)
- Average
- 17.02%
- Highest days to cover
- 11.18 (29 May 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.59% | 7.03 | |
| 30 Jan 2026 | 12.66% | 7.83 | |
| 13 Feb 2026 | 12.57% | 8.28 | |
| 27 Feb 2026 | 11.95% | 8.15 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 12.91% | 6.19 | |
| 31 Mar 2026 | 15.27% | 7.85 | |
| 15 Apr 2026 | 15.44% | 6.93 | |
| 30 Apr 2026 | 14.68% | 9.50 | |
| 15 May 2026 | 14.04% | 9.98 | 10-Q filed, results (8-K) |
| 29 May 2026 | 15.09% | 11.18 | |
| 15 Jun 2026 | 16.49% | 10.40 | |
| 30 Jun 2026 | 18.84% | 5.87 | |
| 15 Jul 2026 | 21.01% | 4.99 | |
| 31 Jul 2026 | 21.21% | 9.42 | |
| 14 Aug 2026 | 23.33% | 6.95 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 27.58% | 10.81 | |
| 15 Sep 2026 | 23.64% | 6.18 |
See also: Vera Therapeutics, Inc. Class's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.